The Evolution of GLP-1 Medications in Germany: A Comprehensive Guide to Diabetes and Obesity ManagementThe landscape of metabolic health has actually undergone a seismic shift over the last decade, driven mostly by the development of Glucagon-like peptide-1 (GLP-1) receptor agonists. In Germany-- a country typically referred to as the "drug
